Asia Pacific Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type (Bioreactors/Fermenters, Cell Culture, Filters, Bags and Containers, and Others), Workflow (Media Preparation, Cell Culture, and Cell Separation), Usage Type (Single-use and Multi-use), and Mode (In-house and Outsourced)
The Asia Pacific upstream bioprocessing market was valued at US$ 1,976.10 million in 2022 and is expected to reach US$ 5,678.99 million by 2030; it is estimated to grow at a CAGR of 14.1% from 2022... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe Asia Pacific upstream bioprocessing market was valued at US$ 1,976.10 million in 2022 and is expected to reach US$ 5,678.99 million by 2030; it is estimated to grow at a CAGR of 14.1% from 2022 to 2030.Technological Advancements Boost Asia Pacific Upstream Bioprocessing Market. The upstream bioprocessing market is experiencing a wave of technological advancements, presenting considerable industry opportunities. These advancements include innovative developments in cell culture systems, bioreactor design, process monitoring, and control, as well as the integration of automation and digitalization. In September 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system. Repligen's XCell Alternating Tangential Flow (ATF) upstream intensification technology has been integrated into the Sartorius Biostat stirred-tank reactor (STR). This bioreactor technology is designed to make the application of N perfusion and intensified seed train easier for biopharmaceutical firms. An embedded XCell ATF hardware and software module that combines integrated process analytical technologies with predefined advanced control recipes is incorporated into Biostat STR. This module is intended to simplify the management of cell growth and enhance cell retention in perfusion procedures, eliminating the need for a separate cell retention control tower. Such modern products feature enhanced process efficiency, scalability, and adaptability, which are crucial for meeting the evolving demands of biopharmaceutical production. Advanced cell culture media formulations and next-generation bioreactor technologies are contributing to the optimization of upstream bioprocessing, in turn, enabling higher product yields, improved product quality, and the efficient production of complex biologics. The ongoing integration of advanced analytics and real-time process monitoring is revolutionizing data-driven decision-making in bioprocessing, driving precision and process optimization opportunities. Progress in biotechnology also fosters the development of flexible and modular manufacturing platforms. Additionally, the convergence of machine learning, artificial intelligence, and predictive analytics is paving the way for predictive bioprocessing, thereby unlocking proactive process control, quality assurance, and cost optimization opportunities. Thus, technological advancements in upstream bioprocessing are reshaping the industry, presenting new avenues for innovation, efficiency, and adaptability. Asia Pacific Upstream Bioprocessing Market Overview The Asia Pacific upstream bioprocessing market is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. The market in this region is expected to grow at the highest CAGR during 2022-2030. China, India, and Japan are three major contributors to the growth of the market in Asia Pacific, which is mainly driven by rising demand for bioreactors as well as an increase in research centers and government funding. Moreover, many international market players are focusing on countries in Asia Pacific for geographic expansion and other strategies. Asia Pacific Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million) Asia Pacific Upstream Bioprocessing Market Segmentation The Asia Pacific upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Asia Pacific upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022. Based on workflow, the Asia Pacific upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022. Based on usage type, the Asia Pacific upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022. Based on mode, the Asia Pacific upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022. Based on country, the Asia Pacific upstream bioprocessing market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific upstream bioprocessing market share in 2022. Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Asia Pacific upstream bioprocessing market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. Asia Pacific Upstream Bioprocessing Market Landscape 4.1 Overview 4.2 PEST Analysis 5. Asia Pacific Upstream Bioprocessing Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Commercial Use of Single-Use Bioreactors 5.1.2 Outsourcing of Biopharmaceutical Manufacturing 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries 5.2 Market Restraints 5.2.1 Stringent Regulatory Framework 5.3 Market Opportunities 5.3.1 Technological Advancements 5.4 Future Trends 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry 5.5 Impact of Drivers and Restraints: 6. Upstream Bioprocessing Market - Asia Pacific Analysis 7. Asia Pacific Upstream Bioprocessing Market Analysis - by Product Type 7.1 Bioreactors/Fermenters 7.1.1 Overview 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.2 Cell Culture 7.2.1 Overview 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.3 Filters 7.3.1 Overview 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.4 Bags and Containers 7.4.1 Overview 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.5 Others 7.5.1 Overview 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8. Asia Pacific Upstream Bioprocessing Market Analysis - by Workflow 8.1 Media Preparation 8.1.1 Overview 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8.2 Cell Culture 8.2.1 Overview 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8.3 Cell Separation 8.3.1 Overview 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 9. Asia Pacific Upstream Bioprocessing Market Analysis - by Usage Type 9.1 Single-use 9.1.1 Overview 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 9.2 Multi-use 9.2.1 Overview 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 10. Asia Pacific Upstream Bioprocessing Market Analysis - by Mode 10.1 In-house 10.1.1 Overview 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 10.2 Outsourced 10.2.1 Overview 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11. Asia Pacific Upstream Bioprocessing Market - Country Analysis 11.1 Asia Pacific Market Overview 11.1.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country 11.1.1.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country 11.1.1.2 China 11.1.1.3 China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.3.1 China: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.3.2 China: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.3.3 China: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.3.4 China: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.4 Japan 11.1.1.5 Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.5.1 Japan: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.5.2 Japan: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.5.3 Japan: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.5.4 Japan: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.6 India 11.1.1.7 India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.7.1 India: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.7.2 India: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.7.3 India: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.7.4 India: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.8 Australia 11.1.1.9 Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.9.1 Australia: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.9.2 Australia: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.9.3 Australia: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.9.4 Australia: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.10 South Korea 11.1.1.11 South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.11.1 South Korea: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.11.2 South Korea: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.11.3 South Korea: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.11.4 South Korea: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.12 Rest of Asia Pacific 11.1.1.13 Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.13.1 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.13.2 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.13.3 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.13.4 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Mode 12. Industry Landscape 12.1 Overview 12.2 Growth Strategies in Upstream Bioprocessing Market 12.3 Organic Growth Strategies 12.3.1 Overview 12.4 Inorganic Growth Strategies 12.4.1 Overview 13. Company Profiles 13.1 Thermo Fisher Scientific Inc 13.1.1 Key Facts 13.1.2 Business Description 13.1.3 Products and Services 13.1.4 Financial Overview 13.1.5 SWOT Analysis 13.1.6 Key Developments 13.2 Esco Micro Pte Ltd 13.2.1 Key Facts 13.2.2 Business Description 13.2.3 Products and Services 13.2.4 Financial Overview 13.2.5 SWOT Analysis 13.2.6 Key Developments 13.3 Sartorius AG 13.3.1 Key Facts 13.3.2 Business Description 13.3.3 Products and Services 13.3.4 Financial Overview 13.3.5 SWOT Analysis 13.3.6 Key Developments 13.4 Danaher Corp 13.4.1 Key Facts 13.4.2 Business Description 13.4.3 Products and Services 13.4.4 Financial Overview 13.4.5 SWOT Analysis 13.4.6 Key Developments 13.5 Getinge AB 13.5.1 Key Facts 13.5.2 Business Description 13.5.3 Products and Services 13.5.4 Financial Overview 13.5.5 SWOT Analysis 13.5.6 Key Developments 13.6 Merck KGaA 13.6.1 Key Facts 13.6.2 Business Description 13.6.3 Products and Services 13.6.4 Financial Overview 13.6.5 SWOT Analysis 13.6.6 Key Developments 13.7 Corning Inc 13.7.1 Key Facts 13.7.2 Business Description 13.7.3 Products and Services 13.7.4 Financial Overview 13.7.5 SWOT Analysis 13.7.6 Key Developments 13.8 Entegris Inc 13.8.1 Key Facts 13.8.2 Business Description 13.8.3 Products and Services 13.8.4 Financial Overview 13.8.5 SWOT Analysis 13.8.6 Key Developments 14. Appendix 14.1 About The Insight Partners 14.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(映画・娯楽)の最新刊レポートThe Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(asia)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/22 10:26 151.74 円 164.56 円 199.74 円 |